Order Article Reprints

Kutkat O, Kandeil A, Moatasim Y, Elshaier YAMM, El-Sayed WA, Gaballah ST, El Taweel A, Kamel MN, El Sayes M, Ramadan MA, et al. In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses. Pharmaceuticals. 2022; 15(3):351. https://doi.org/10.3390/ph15030351

Kutkat, Omnia, Ahmed Kandeil, Yassmin Moatasim, Yaseen A. M. M. Elshaier, Wael A. El-Sayed, Samir T. Gaballah, Ahmed El Taweel, Mina Nabil Kamel, Mohamed El Sayes, Mohammed A. Ramadan, and et al. 2022. "In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses" Pharmaceuticals 15, no. 3: 351. https://doi.org/10.3390/ph15030351

Kutkat, O., Kandeil, A., Moatasim, Y., Elshaier, Y. A. M. M., El-Sayed, W. A., Gaballah, S. T., El Taweel, A., Kamel, M. N., El Sayes, M., Ramadan, M. A., El-Shesheny, R., Abdel-Megeid, F. M. E., Webby, R., Kayali, G., & Ali, M. A. (2022). In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses. Pharmaceuticals, 15(3), 351. https://doi.org/10.3390/ph15030351